Login / Signup

Response by van der Stuijt et al to Letter Regarding Article, "Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial".

Willeke van der StuijtLonneke SmedingLouise R A Olde NordkampReinoud E Knops
Published in: Circulation (2022)
Keyphrases
  • cardiac resynchronization therapy
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • left ventricular
  • heart failure
  • stem cells
  • open label
  • cell therapy
  • mesenchymal stem cells